NCT05866445Completed
An Updated Wearable Magnetic Flux Device to Optimize Blood Pressure Control
Source: ClinicalTrials.gov · Last updated 5 Jun 2025
Brief summary (registry, in English)
The goal of this study involving a wearable magnetic flux device is to study the impact of static magnetic flux on blood pressure control in hypertensive and normotensive populations. The main objectives are: 1. Study the safety and efficacy of static magnetic flux on blood pressure control in normal and hypertensive patients. 2. Incorporate this into a portable, wearable device to increase availability and outreach. Participants will be required to wear a wearable BP device, an ambulatory BP and answer a questionnaire for this study. Researchers will compare between hypertensive and normotensive groups to achieve objective of this study.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 180 (actual)
- First submitted
- 10 May 2023
- Start date
- 15 Mar 2023
- Primary completion date
- 30 Apr 2025
- Lead sponsor
- National Heart Centre Singapore
- Diseases
- High blood pressure
- NCT number
- NCT05866445
What you commit to
- Study type: Interventional
- Participants enrolled: 180
- From 15 Mar 2023 to the primary completion date, 30 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Recent change (\<1month) in blood pressure medications
- Prior stroke
- Prior ischemic heart disease
- Prior peripheral vascular heart disease
- Prior carotid stenosis or bruit
- Presence of metallic implants (e.g. ICD, pacemaker, etc)
Other illness
- Allergy to device material/skin allergy
Other
- SBP \<100mmHg, DBP\<50mmHg
- SBP\>180mmHg, DBP \>110mmHg
- Pregnancy
- Breast feeding
Who the study is looking for
- For normotensive patients, Systolic Blood Pressure 100-139mmHg/ Diastolic Blood Pressure 50-89mmHg
- For hypertensive patients, SBP 140-180mmHg, DBP 90-110mmHg (no change in blood pressure medications in last one month) OR Hypertensive patients with stable blood pressure (SBP not \<100, DBP not \<50) well controlled on medication
Age in the registry: 21 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Heart Centre Singapore Coordinator of this site? Confirm its status | Singapore | Singapore | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.